Boston Therapeutics

Boston Therapeutics is a pharmaceutical company focused on the development, manufacturing, and commercialization of novel compounds to address unmet medical needs in the fields of diabetes and inflammatory diseases. The company's products are based on a complex carbohydrate drug design platform applied in both prescription and over-the-counter products. Key products include: PAZ320, a non-systemic chewable therapeutic compound designed to reduce post-meal blood sugar spikes; SUGARDOWN®, a non-systemic chewable complex carbohydrate dietary supplement aimed at alleviating post-meal blood sugar elevation; and IPOXYN™, a systemic, injectable, complex carbohydrate-based oxygen therapy for limb ischemia.